In addition, inhibition of SphK1, using both FTY720 and siRNA, could suppress ACC progression in vitro and in vivo, suggesting that SphK1 inhibition might represent new and potential strategies against human ACC. Here, SPHK1 is linked to adrenal cortex carcinoma.